These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34253872)

  • 1. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.
    Wang X; Liu Q; Halfdanarson ÓÖ; Zoega H; Sadr-Azodi O; Engstrand L; Fall K; Brusselaers N
    Br J Cancer; 2021 Sep; 125(6):893-900. PubMed ID: 34253872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study.
    Liu Q; Wang X; Engstrand L; Sadr-Azodi O; Fall K; Brusselaers N
    BMJ Open; 2024 Jul; 14(7):e079591. PubMed ID: 38960460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
    De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
    World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors Worsen Colorectal Cancer Outcomes in Patients Treated with Bevacizumab.
    Wu CC; Fang CY; Chiou WY; Chen PT; Hsu TW; Hung SK; Liao YT; Hung CS; Tsai JH
    Cancers (Basel); 2024 Oct; 16(19):. PubMed ID: 39409998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer.
    Hálfdánarson ÓÖ; Pottegård A; Lund SH; Ogmundsdottir MH; Ogmundsdottir HM; Zoega H
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):484-491. PubMed ID: 31872571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy.
    Kichenadasse G; Miners JO; Mangoni AA; Karapetis CS; Hopkins AM; Sorich MJ
    J Natl Compr Canc Netw; 2021 May; 19(9):1037-1044. PubMed ID: 33951613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children.
    Lassalle M; Zureik M; Dray-Spira R
    JAMA Pediatr; 2023 Oct; 177(10):1028-1038. PubMed ID: 37578761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Ji J; Sundquist J; Sundquist K
    Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population-based cohort study.
    Lycke KD; Christiansen CF; Lund JL; Iversen LH; Nørgaard M
    Colorectal Dis; 2019 Jun; 21(6):651-662. PubMed ID: 30740875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.
    Lin WY; Wang SS; Kang YN; Porpiglia AS; Chang Y; Huang CH; Bhimani R; Abdul-Lattif E; Azmat M; Wang TH; Lin YS; Chang YC; Chi KY
    Front Pharmacol; 2022; 13():1048980. PubMed ID: 36578549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor use and cancer mortality.
    Tvingsholm SA; Dehlendorff C; Østerlind K; Friis S; Jäättelä M
    Int J Cancer; 2018 Sep; 143(6):1315-1326. PubMed ID: 29658114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
    Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
    Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
    Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.